DNAJA1 Antibody [J3K12]

N° de catalogue F4809

Imprimer

Description biologique

Spécificité L'anticorps DNAJA1 [J3K12] détecte les niveaux endogènes de la protéine DNAJA1 totale.
Contexte DNAJA1 (DnaJ homolog subfamily A member 1) est un co-chaperon Hsp40 de type I cytosolique, essentiel pour la protéostase et la signalisation du stress. Il comporte un domaine J N-terminal (résidus 4–70, avec un motif HPD en His33-Pro34-Asp35 crucial pour la stimulation de l'ATPase Hsp70), un domaine à doigt de zinc C4 (aa 78–115, contenant huit cystéines qui coordonnent deux ions Zn²⁺ pour sonder les patchs hydrophobes sur les protéines clientes), un linker flexible riche en glycine/phénylalanine (aa 116–165), et un domaine de liaison au substrat C-terminal (aa 166–397) comprenant des feuillets β et des hélices α empilés, ainsi qu'un motif CTIL355–358 farnésylé pour une fixation dynamique au RE ou à la membrane plasmatique. Dans le cycle du chaperon Hsp70, l'hélice α II du domaine J s'ancre au domaine de liaison aux nucléotides de Hsp70, accélérant l'hydrolyse de l'ATP plus de 1000 fois et piégeant les substrats dans l'état lié à l'ADP. Les doigts de zinc délivrent des clients tels que le p53 mutant conformationnel (où DNAJA1 se lie au domaine central de mutp53 pour bloquer stériquement l'ubiquitination E3 de CHIP en Lys620, stabilisant les conformères oncogènes qui entraînent l'invasion du carcinome pancréatique et du cholangiocarcinome via les filopodes médiés par Cdc42/Rac1), CFTR ΔF508 (dirigeant le triage pour la rétention RE et la rétrotranslocation via Hsc70), les fibrilles de tau (facilitant la désagrégation indépendante de Hsp104), et les complexes d'import nucléaire de la grippe PB2/PA. DNAJA1 restreint également l'hyperactivation de JNK/c-Jun sous stress oxydatif et RE en favorisant la séquestration de SAPK médiée par Hsc70, empêchant ainsi la perméabilisation de la membrane externe mitochondriale et l'apoptose médiées par BAX. De plus, il module l'agrégation de polyQ-htt dans les modèles de Huntington et le trafic du canal hERG. La régulation négative de DNAJA1 dans les tumeurs de PDAC augmente paradoxalement la persistance de mutp53 et la croissance tumorale, sensibilisant ces tumeurs aux inhibiteurs du domaine J (tels que A11, qui cible Y7/K44/Q47 pour perturber l'interaction mutp53 et promouvoir sa clairance protéasomale).

Informations dutilisation

Application WB, FCM Dilution
WB FCM
1:10000 - 1:50000 1:10 - 1:100
Réactivité Human
Source Rabbit Monoclonal Antibody MW 45 kDa
Tampon de stockage PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Stockage
(À partir de la date de réception)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:10000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

Références

  • https://pubmed.ncbi.nlm.nih.gov/24512202/
  • https://pubmed.ncbi.nlm.nih.gov/33229560/

Données dapplication

WB

Validé par Selleck

  • F4809-wb
    Lane 1: HepG2, Lane 2: SK-BR-3, Lane 3: Jurkat, Lane 4: Raji